Becton, Dickinson vs Edwards Lifesciences

Becton, Dickinson (BDX), health care, and Edwards Lifesciences (EW), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Edwards Lifesciences is worth $61.8B on the stock market and Becton, Dickinson $58.8B: Edwards Lifesciences is valued at 5% more. Becton, Dickinson trades at 42.7 times earnings and Edwards Lifesciences at 62.5; operating margins in their latest fiscal years were 11.8% and 20.8%. Over the past year Becton, Dickinson's share price has moved +43.2% and Edwards Lifesciences's +27.5%.

Key facts

Becton, Dickinson market value
$58.8B
Edwards Lifesciences market value
$61.8B
Becton, Dickinson P/E
42.7
Edwards Lifesciences P/E
62.5
Becton, Dickinson revenue
$21.8BFY to 2025-09-30
Edwards Lifesciences revenue
$6.1BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Becton, Dickinson vs Edwards Lifesciences: every measure side by side
Measure Becton, Dickinson Edwards Lifesciences
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-09-302025-12-31
Size
Market cap$58.8Blower$61.8Bhigher
Revenue$21.8Bhigher$6.1Blower
Earnings$1.7Bhigher$1.1Blower
Employees60,000higher16,000lower
Total assets$55.3Bhigher$13.7Blower
Valuation
P/E42.7lower62.5higher
P/S2.7lower10.2higher
P/B2.4lower5.7higher
Dividend yield0.00%0.00%
Profitability
Operating margin11.8%lower20.8%higher
Balance sheet
Net assets$25.4Bhigher$10.3Blower
Total liabilities$29.9Bhigher$3.4Blower
Total debt$19.2Bhigher$598.3Mlower
Cash on hand$641Mlower$2.9Bhigher
Price change
Today-0.23%lower+0.29%higher
1 year+43.2%higher+27.5%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns BDX · Who owns EW

Further comparisons

Learn

Questions and answers

Which is bigger, Becton, Dickinson or Edwards Lifesciences?

By market value, Edwards Lifesciences is the larger: $61.8B against $58.8B for Becton, Dickinson. By revenue in its latest fiscal year, Becton, Dickinson is the larger: $21.8B against $6.1B for Edwards Lifesciences.

Which has the higher P/E ratio?

Edwards Lifesciences: 62.5, against 42.7 for Becton, Dickinson. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Edwards Lifesciences: 20.8%, against 11.8% for Becton, Dickinson. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Becton, Dickinson: $19.2B, against $598.3M for Edwards Lifesciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Becton, Dickinson and Edwards Lifesciences?

None of the tracked superinvestors holds both in their latest 13F filing. 11 hold Becton, Dickinson and 9 hold Edwards Lifesciences.

Cite this page

Funkfolio, “Becton, Dickinson vs Edwards Lifesciences”, data as of 17 November 2026. https://funkfolio.com/compare/bdx-vs-ew

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.